Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Men

NCT01694498 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

183

Enrollment

INDUSTRY

Sponsor class

Conditions

Nocturia

Interventions

DRUG: A: Desmopressin 25 µg
DRUG: B. Desmopressin 50 µg
DRUG: Placebo

Sponsor

Ferring Pharmaceuticals